EndoGlow

Executive Summary

EndoGlow has developed the GreenEgg fluorescent manipulator, a novel device that integrates fluorescence into surgical manipulators to provide real-time transillumination during minimally invasive gynecologic, colorectal, and urologic procedures. By enhancing visualization of anatomical structures, the device aims to improve surgical precision and reduce complications. Founded in 2020 and based in San Francisco, the company is privately held and has not disclosed financing or valuation details. The technology addresses a significant unmet need in minimally invasive surgery, where clear visualization is critical. With an initial focus on three surgical specialties, EndoGlow has the potential to expand into additional applications, positioning it as a niche but impactful player in the medical device market.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for expanded indications (colorectal and urologic)60% success
• Q1 2027First commercial sales and revenue generation50% success
• Q3 2026Publication of clinical outcomes data in peer-reviewed journal70% success